Mckesson is a medical distribution company located in Texas, United States, which is part of the Healthcare sector, and is traded under the ticker MCK on the NYSE exchange.
Mckesson stock last closed at $978.71, down 1.71% from the previous day, and has increased 52.05% in one year. It has overperformed other stocks in the Medical Distribution industry by 0.03 percentage points. Mckesson stock is currently +56.26% from its 52-week low of $626.33, and -2.03% from its 52-week high of $999.00.
As of Mar 4, 2026, there are 122.49M MCK shares outstanding. The market value of MCK is $119.88B. In the past 24 hours, 550,000 MCK shares were traded.
You need an online brokerage account to access the NYSE market and buy MCK stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal info so you are able to invest in MCK today.
Now that you have finished signing up on the best stock app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your new brokerage account.
After you have figured out the best place to buy Mckesson stock, it's critical to research their stock before you buy, so you actually understand the risk as well as the opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on MCK's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge MCK's fair value.
Using relative valuations ratios:
You can access additional valuation analysis on MCK's stock here.
Out of 13 Wall Street analysts who give forecasts on MCK, the consensus analyst rating on Mckesson is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Kevin Caliendo, a top 15% analyst from UBS maintains MCK with a strong buy rating and raises their MCK price target from $920.00 to $980.00, on Nov 6, 2025.
Eric Coldwell, a top 23% analyst from Baird maintains MCK with a buy rating and raises their MCK price target from $873.00 to $927.00, on Nov 6, 2025.
Erin Wright, a top 5% analyst from Morgan Stanley maintains MCK with a strong buy rating and raises their MCK price target from $857.00 to $916.00, on Nov 6, 2025.
Morgan Stanley's Erin Wright raised their price target on Mckesson (NYSE: MCK) by 6.9% from $857 to $916 on 2025/11/06. The analyst maintained their Strong Buy rating on the stock.
McKesson reported its Q2 2026 earnings.
Wright said organic growth that remains strong accounted for "another beat & raise quarter."
Management's FY 2026 guidance showcased the company's operational momentum, the analyst continued.
However, from an investment perspective, Wright cautioned that but adds that the stock's reaction to the print "might be muted" by "the high bar" set for McKesson.
For Q2 2026, McKesson reported:
For FY 2026, management guided:
CEO Brian Tyler commented: “McKesson’s second quarter results underscore the strength of our differentiated assets, capabilities, and continued momentum as a diversified healthcare services leader.
"We delivered record revenue in the quarter of $103 billion, increasing 10% and Adjusted Earnings per Diluted Share accelerating 39% compared to the prior year.
"These results reflect disciplined execution of our enterprise strategy – advancing growth in oncology and multispecialty and biopharma services.
"We remain confident in our ability to create value for our customers, partners, employees, and shareholders.
“These achievements reflect the dedication of McKesson employees and their unwavering commitment to delivering measurable value to all stakeholders.
"Our strategic focus in our growth pillars of oncology and multispecialty and biopharma services, combined with disciplined execution, continues to drive sustainable long-term growth.
"Following our strong first half performance, sustained momentum across our portfolio, and confidence in the outlook for the remainder of the year, we are raising our fiscal 2026 Adjusted Earnings per Diluted Share guidance by $0.30 to a range of $38.35 to $38.85.
"This builds on the $0.80 increase announced at Investor Day in September 2025.”
Brian Tanquilut, a top 14% analyst from Jefferies maintains MCK with a strong buy rating and raises their MCK price target from $820.00 to $900.00, on Oct 14, 2025.
Elizabeth Anderson, a bottom 19% analyst from Evercore ISI Group maintains MCK with a buy rating and raises their MCK price target from $800.00 to $825.00, on Sep 24, 2025.
You can dive deeper into what analysts are saying on the Mckesson stock forecast page.
Last year, MCK earnings were $4.34B. During the past 4 year, MCK's earnings have gone up by 40.94% per year. This was faster than the Medical Distribution industry average of 21.57%.
Last year, MCK revenue was $397.96B. In the past five year, MCK's revenue has grown by 10.86% per year. This was faster than the Medical Distribution industry average of 10.12%.
You can analyze MCK's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at MCK have sold more shares than they have bought.
Michele Lau, EVP and Chief Legal Officer of MCK, was the latest MCK insider to sell. They sold $2,697,750.00 worth of MCK shares on Mar 2, 2026.
Research more about who owns MCK shares here.
Mckesson pays a dividend of 0.24%, compared to the Medical Distribution industry's average dividend yield of 0.59%. If you owned $1,000 of MCK stock, you would have been paid $2.40 last year.
Mckesson dividend payments have consistently grown over the past decade and have remained stable.
Find more data about Mckesson dividend yield and history here.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary options:
Click the Open button and your broker will place the order.
If you need additional info about buying stocks on eToro, click the how to video below:
Now that you own some MCK stock, you'll want to keep up with your new company.
Make a watchlist to track the latest developments regarding your MCK stock.
To reiterate, here are the 6 steps you need to take to buy Mckesson stock right now:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Mckesson, get started below.